SecBot SecBot
8-K ·Filed May 7, 2026

EDAP

EDAP TMS SA
MIXED
Impact 6/10
Horizonweeks Processed6mo ago SEC0001171843-26-003113
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

The HIFU growth story is intact and accelerating, but the company is burning cash rapidly ($5.4M in Q1 alone, leaving only $15M). With a $135M market cap and no path to near-term profitability, the stock will likely remain range-bound until either (a) the company demonstrates operating leverage or (b) announces a capital raise. Watch for the June 1 Investor Day for any strategic updates.

DirectionMixed
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$4.16
T+0 close · May 7, 2026 · via day close
Latest settled
+12.74%
T+20 · $4.69
Vs SPY
+9.60%
α at T+20
Next horizon
T+60
due 4mo ago
  1. T+0 · May 7 $4.16entry
  2. T+1 · 6mo ago −0.72%α −1.55% · $4.13
  3. T+5 · 6mo ago 0.00%α −1.50% · $4.16
  4. T+20 · 6mo ago +12.74%α +9.60% · $4.69
  5. T+60 · due 4mo ago Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

EDAP reported Q1 2026 total revenue of $17.8M (up 25% YoY from $14.3M), driven by record HIFU revenue of $11.6M (+78% YoY). However, the net loss widened to $9.1M (-$0.24/share) from $7.4M (-$0.20/share) a year ago, and the company reiterated (not raised) its 2026 guidance. The HIFU business is accelerating, but the company remains deeply unprofitable with negative operating cash flow and a rapidly shrinking cash balance.

Key Financial Metrics

EPS
−$0.24
est −$0.22 · -9.1%
Revenue
$17.8M
est $16.6M · +7.2% · +24.9% YoY
Rating
in line
Guidance
$72.0M-$80.0M
maintained
Gross Margin
45.7%

Key Facts

  • Q1 2026 total revenue $17.8M vs $14.3M YoY (+25%)
  • HIFU revenue $11.6M, up 78% YoY, record quarter
  • 11 Focal One systems sold vs 6 YoY (+83%)
  • U.S. Focal One procedures up 53% YoY
  • Gross margin improved to 45.7% from 42.0% YoY
  • Net loss widened to $9.1M (-$0.24/share) from $7.4M (-$0.20/share)
  • Operating loss $7.4M vs $6.3M YoY
  • Cash burn continues: cash dropped to $15.0M from $20.5M in 3 months
  • 2026 guidance reiterated (not raised): HIFU $50-54M, total $72-80M
  • HIFI-2 study published in European Urology Oncology, positive salvage HIFU data

Financial Impact

HIFU revenue growth of 78% YoY to $11.6M is the key positive; net loss of $9.1M and cash burn of $5.4M in the quarter are the key negatives

revenuehifuRevenuenetLosscashPositiongrossMargin

Risk Factors

  • Cash burn: $15M cash at March 31 vs $20.5M at Dec 31, less than 3 quarters of runway at current burn rate
  • No EPS or revenue consensus beat, EPS miss vs Street estimates
  • Guidance reiterated, not raised, despite strong Q1, suggests management sees H2 headwinds
  • Non-core ESWL/Distribution revenue declining ($6.2M vs $7.8M YoY) as company pivots to HIFU

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
67% bullish (9 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001171843-26-003113
Document: f8k_050726.htm0001171843-26-003113
Document: 0001171843-26-003113-index-headers.html0001171843-26-003113
Document: 0001171843-26-003113-index.html0001171843-26-003113
Document: 0001171843-26-003113.txt0001171843-26-003113
8-K Data (Synthetic)0001171843-26-003113

Track record

12 reports on EDAP

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Aug 17, 202613w ago Insider Cluster Mixed 5/10 No price data
  2. May 29, 202624w ago 8-K Neutral 4/10 Entry $4.32 to $5.10 ▲ +18.06% +19.85% vs SPY
  3. May 14, 202626w ago DEFA14A Bearish 6/10 Entry $4.13 to $4.77 ▼ −15.50% −16.35% vs SPY
  4. May 14, 202626w ago DEFA14A Neutral 3/10 Entry $4.13 to $4.77 ▲ +15.50% +16.35% vs SPY
  5. May 14, 202626w ago Press Release Neutral 3/10 Entry $4.13 to $4.77 ▲ +15.50% +16.35% vs SPY
  6. May 7, 202627w ago 8-K Mixed 6/10 Viewing Entry $4.16 to $4.69 ▲ +12.74% +9.60% vs SPY
  7. Apr 16, 202630w ago Press Release Neutral 1/10 Entry $3.59 to $4.16 ▲ +15.88% +10.06% vs SPY
  8. Apr 1, 202632w ago EFFECT Neutral 4/10 Entry $3.53 to $3.31 ▼ −6.23% −15.95% vs SPY
  9. Mar 26, 202633w ago S-3/A Neutral 4/10 Entry $3.73 to $3.22 ▼ −13.67% −26.41% vs SPY
  10. Mar 25, 202633w ago S-3 Neutral 5/10 Entry $3.77 to $3.22 ▼ −14.59% −25.25% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens Wed (10h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 7, 2026